- Home
- WALD
WALD
Waldencast plc
as of 09-16-2026 10:05am EST
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
| Founded: | 1988 | Country: | United Kingdom |
| Employees: | N/A | City: | WHITE PLAINS |
| Market Cap: | 187.3M | IPO Year: | 2021 |
| Target Price: | $2.00 | AVG Volume (30 days): | 257.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.72 - $3.22 | Next Earning Date: | 03-13-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 9.89% | Revenue Growth (next year): | 4.31% |
| P/E Ratio: | -8.62 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Waldencast plc (WALD)
Director, 10% Owner
Avg Cost/Share
$1.51
Shares
335,000
Total Value
$505,649.00
Owned After
12,587,580
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Souza Cristiano | WALD | Director, 10% Owner | Aug 28, 2026 | Buy | $1.51 | 335,000 | $505,649.00 | 12,587,580 |
Compare WALD vs Leading Stocks
See how WALD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "WALD Waldencast plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.